Literature DB >> 24659871

Role of macrophages and monocytes in hepatitis C virus infections.

Dennis Revie1, Syed Zaki Salahuddin1.   

Abstract

A number of studies conducted over many years have shown that hepatitis C virus (HCV) can infect a variety of cell types. In vivo infection of monocytes, macrophages, and dendritic cells by HCV has been frequently shown by a number of researchers. These studies have demonstrated replication of HCV by detecting the presence of both negative genomic strands and a variety of non-structural HCV proteins in infected cells. In addition, analyses of genome sequences have also shown that different cell types can harbor different HCV variants. Investigators have also done preliminary studies of which cellular genes are affected by HCV infection, but there have not yet been a sufficient number of these studies to understand the effects of infection on these cells. Analyses of in vitro HCV replication have shown that monocytes, macrophages and dendritic cells can be infected by HCV from patient sera or plasma. These studies suggest that entry and cellular locations may vary between different cell types. Some studies suggest that macrophages may preferentially allow HCV genotype 1 to replicate, but macrophages do not appear to select particular hypervariable regions. Overall, these studies agree with a model where monocytes and macrophages act as an amplification system, in which these cells are infected and show few cytopathic effects, but continuously produce HCV. This allows them to produce virus over an extended time and allows its spread to other cell types.

Entities:  

Keywords:  Dendritic cells; Hepatitis C virus; Hepatitis C virus replication; Macrophages; Monocytes

Mesh:

Year:  2014        PMID: 24659871      PMCID: PMC3961986          DOI: 10.3748/wjg.v20.i11.2777

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  64 in total

1.  Immunohistochemical detection of C-100 hepatitis C virus antigen in formaldehyde-fixed paraffin-embedded liver tissue. Correlation with serum, tissue and in situ RT-PCR results.

Authors:  L Benkoël; P Biagini; F Dodero; X De Lamballerie; P De Micco; A Chamlian
Journal:  Eur J Histochem       Date:  2004 Apr-Jun       Impact factor: 3.188

2.  Dendritic cell susceptibility to hepatitis C virus genotype 1 infection.

Authors:  Maria-Cristina Navas; Anne Fuchs; Evelyne Schvoerer; Alain Bohbot; Anne-Marie Aubertin; Françoise Stoll-Keller
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

3.  A study of susceptibility of primary human Kupffer cells to hepatitis C virus.

Authors:  Cathy Royer; Anne-Marie Steffan; Maria-Cristina Navas; Anne Fuchs; Daniel Jaeck; Françoise Stoll-Keller
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

4.  Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

Authors:  Daniel M Forton; Peter Karayiannis; Nadiya Mahmud; Simon D Taylor-Robinson; Howard C Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection.

Authors:  Nadege Goutagny; Claude Vieux; Evelyne Decullier; Benoit Ligeoix; Alberto Epstein; Christian Trepo; Patrice Couzigou; Genevieve Inchauspe; Christine Bain
Journal:  J Infect Dis       Date:  2004-04-15       Impact factor: 5.226

6.  Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages.

Authors:  Tomasz Laskus; Marek Radkowski; Joanna Jablonska; Karen Kibler; Jeffrey Wilkinson; Debra Adair; Jorge Rakela
Journal:  Blood       Date:  2004-01-22       Impact factor: 22.113

Review 7.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

8.  Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes.

Authors:  Delphine Ducoulombier; Anne-Marie Roque-Afonso; Gaëtana Di Liberto; François Penin; Rachid Kara; Yolande Richard; Elisabeth Dussaix; Cyrille Féray
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

9.  Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8.

Authors:  Marek Radkowski; Agnieszka Bednarska; Andrzej Horban; Janusz Stanczak; Jeffrey Wilkinson; Debra M Adair; Marek Nowicki; Jorge Rakela; Tomasz Laskus
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

10.  Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection.

Authors:  Nadège Goutagny; Ahmed Fatmi; Victor De Ledinghen; François Penin; Patrice Couzigou; Geneviève Inchauspé; Christine Bain
Journal:  J Infect Dis       Date:  2003-05-29       Impact factor: 5.226

View more
  19 in total

1.  Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages.

Authors:  Yuan Liu; Wenbo Wang; Ziying Zou; Zonghai Hu; Quanshui Fan; Jie Xiong
Journal:  Dig Dis Sci       Date:  2018-12-10       Impact factor: 3.199

2.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

3.  Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6.

Authors:  Gokul Swaminathan; Daniel Pascual; Germaine Rival; Renzo Perales-Linares; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  FEBS Lett       Date:  2014-08-14       Impact factor: 4.124

4.  Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.

Authors:  S Schulz; A Landi; R Garg; J A Wilson; S van Drunen Littel-van den Hurk
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

5.  Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Authors:  Yu Zhou; Xu Wang; Li Sun; Li Zhou; Tong-Cui Ma; Li Song; Jian-Guo Wu; Jie-Liang Li; Wen-Zhe Ho
Journal:  FASEB J       Date:  2016-09-07       Impact factor: 5.191

6.  High post-treatment absolute monocyte count predicted hepatocellular carcinoma risk in HCV patients who failed peginterferon/ribavirin therapy.

Authors:  Tsung-Ming Chen; Chun-Che Lin; Pi-Teh Huang; Chen-Fan Wen
Journal:  Tumour Biol       Date:  2015-12-12

7.  HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway.

Authors:  Qianqian Zhang; Yang Wang; Naicui Zhai; Hongxiao Song; Haijun Li; Yang Yang; Tianyang Li; Xiaolin Guo; Baorong Chi; Junqi Niu; Ian Nicholas Crispe; Lishan Su; Zhengkun Tu
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

8.  Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016).

Authors:  Aidan M Nikiforuk; Mohammad Ehsanul Karim; David M Patrick; Agatha N Jassem
Journal:  BMC Public Health       Date:  2021-07-13       Impact factor: 3.295

9.  Piscine orthoreovirus (PRV) in red and melanised foci in white muscle of Atlantic salmon (Salmo salar).

Authors:  Håvard Bjørgen; Øystein Wessel; Per Gunnar Fjelldal; Tom Hansen; Harald Sveier; Håkon Rydland Sæbø; Katrine Bones Enger; Eirik Monsen; Agnar Kvellestad; Espen Rimstad; Erling Olaf Koppang
Journal:  Vet Res       Date:  2015-09-08       Impact factor: 3.683

10.  HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes.

Authors:  Yizhong Wang; Jieliang Li; Xu Wang; Yu Zhou; Ting Zhang; Wenzhe Ho
Journal:  Hepat Mon       Date:  2015-08-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.